Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 4 analysts offering 12 month price targets for Ocuphire Pharma Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a 1,253.38% increase from the last price of 1.33.
High | 1,403.8% | 20.00 |
Med | 1,253.4% | 18.00 |
Low | 727.1% | 11.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -20.77% |
Average growth rate | +33.55% |
More ▼
Revenue history & estimates in USD
Average growth rate | +26.30% |
Average growth rate | +2,204.50% |
More ▼